Juno Hires Sunil Agarwal, a Former Genentech Scientist, as Head of R&D

Biotech also plans to establish a San Francisco research group to accelerate drug development as competition intensifies.
 
 

Juno Therapeutics has recruited former Genentech researcher Sunil Agarwal to head up a revamped research organization, according to an article in Endpoints, a biotech newsletter. The post references an internal memo it obtained in which CEO Hans Bishop told Juno's staff that the company would announce the new hire before the market opens Monday. Read the whole story here.

 

Related Content

Sponsored

“This office is the Space Needle amongst the rest of the Consulting companies in Seattle” summarized one employee who helped AIM make the list of WA's 100 Best Companies to Work For in 2017.

Xuchen Yao and Guoguo Chen were interns at Google working on language-processing technology when Amazon introduced Echo, the media-streaming device equipped with a voice-activated intelligent assistant, which is triggered when the user says the hotword “Alexa.”  

When it comes to taking on global warming, few ideas are as audacious as the one put forward by Mark Anderson, the Friday Harbor-based CEO of Strategic News Service who has a knack for identifying technology trends.

Ever since his school days on Mercer Island, Jake Rubin has dreamed of creating a holodeck like the one on the Star Trek television series — a virtual reality experience so immersive that it is perceived as real.